Spanish Red Biotech Pipeline

Merck KGaA

Evobrutinib  (BTK inhibitor)

Type: Biodrugs/ Drugs
Therapeutic area: Central Nervous System
Indication: Relapsing multiple sclerosis
Phase: 3Phase III, 2Phase II in Spain, 1Phase I in Spain